Eletium Sceletium Tortuosum Extract
Also known as: Kanna, Channa, Zembrin®, Sceletium tortuosum
Overview
Sceletium tortuosum is a succulent plant native to South Africa, traditionally used by indigenous peoples for mood enhancement and stress relief. The extract is primarily utilized for its anxiolytic (anxiety-reducing), antidepressant, and cognitive-enhancing properties. Its key characteristics include a dual pharmacological activity: selective serotonin reuptake inhibition (SSRI) and phosphodiesterase-4 (PDE4) inhibition. This dual action is believed to synergistically affect mood and cognition. Research on Sceletium tortuosum is moderately mature, with several randomized controlled trials (RCTs) and mechanistic studies supporting its efficacy and safety. While systematic reviews and meta-analyses are limited, the available evidence is of moderate quality, with well-designed studies indicating its potential benefits. The plant contains various alkaloids, including mesembrine, mesembrenone, mesembrenol, and mesembranol, which are responsible for its therapeutic effects.
Benefits
Sceletium tortuosum extract offers several evidence-based benefits, primarily in mood and cognitive function. It demonstrates significant **anxiety reduction**, as shown in a double-blind, placebo-controlled fMRI study where a single 25 mg dose of standardized extract (Zembrin®) attenuated amygdala reactivity to fearful stimuli and reduced amygdala–hypothalamus coupling, indicating anxiolytic potential. This suggests a direct impact on brain regions associated with fear and anxiety. For **cognitive enhancement**, a randomized, double-blind, placebo-controlled trial found that 25 mg or 50 mg doses of Zembrin® increased frontal brain EEG delta and alpha power during cognitive and emotional challenges, suggesting improvements in attention, memory, and calmness. This indicates a positive effect on brain activity related to cognitive processing. Furthermore, traditional use and some clinical evidence support its role in **mood elevation and stress relief**, likely mediated by its serotonin reuptake inhibition and PDE4 inhibition mechanisms. While effect sizes are statistically significant in reported studies, detailed confidence intervals are not always provided. Benefits appear acutely after single doses, with longer-term effects requiring further characterization in larger RCTs.
How it works
Sceletium tortuosum extract primarily functions as a dual inhibitor of serotonin reuptake and phosphodiesterase-4 (PDE4). Its **serotonin reuptake inhibition** mechanism increases the concentration of serotonin in the synaptic cleft, which is a key neurotransmitter involved in mood regulation, thereby contributing to mood elevation and anxiolysis. Concurrently, its **PDE4 inhibition** elevates intracellular cyclic adenosine monophosphate (cAMP) levels. Increased cAMP is associated with enhanced cognition, neuroplasticity, and anti-inflammatory effects. Specific alkaloids like mesembrenone are potent PDE4 inhibitors. The synergistic combination of these two mechanisms is believed to underpin the extract's beneficial effects on anxiety, mood, and cognitive function. Additionally, the extract exhibits antioxidant and mild anti-inflammatory properties in human monocytes and astrocytes, contributing to neuroprotection.
Side effects
Overall, Sceletium tortuosum extracts, particularly standardized forms, are considered safe at studied doses (25–50 mg). Common side effects are not well documented in controlled trials and appear to be minimal. However, there is a theoretical risk of increased adverse effects with higher doses or extracts rich in certain alkaloids, such as Δ7-mesembrenone, which showed higher adverse potential in in vitro studies. While no significant drug interactions or contraindications have been conclusively reported, caution is strongly advised when combining Sceletium tortuosum with other serotonergic agents, such as selective serotonin reuptake inhibitors (SSRIs) or monoamine oxidase inhibitors (MAOIs), due to the theoretical risk of serotonin syndrome. Serotonin syndrome is a potentially serious condition caused by excessive serotonin activity in the brain. Symptoms can range from mild (tremor, diarrhea) to severe (muscle rigidity, fever, seizures). Due to a lack of sufficient safety data, Sceletium tortuosum is not recommended for use in special populations, including pregnant or nursing individuals, and children. Users should consult a healthcare professional before combining this supplement with any medications or if they have pre-existing medical conditions.
Dosage
The minimum effective dose for Sceletium tortuosum extract, based on clinical trials, is 25 mg of a standardized extract (e.g., Zembrin®), which typically contains approximately 100 μg of total mesembrine alkaloids. The optimal dose range for achieving cognitive and anxiolytic effects is generally considered to be 25–50 mg daily. This dosage range has been supported by randomized controlled trials. The maximum safe dose has not been definitively established, and higher doses may increase the risk of adverse effects. For timing, single doses have demonstrated acute effects on brain activity and anxiety markers within hours of administration. However, studies on the effects of chronic dosing are limited. It is crucial to use standardized extracts, such as Zembrin®, to ensure consistent alkaloid content and predictable pharmacological activity. Oral bioavailability appears adequate, and no specific cofactors are required for absorption.
FAQs
Is it safe to use with antidepressants?
Caution is recommended due to the potential for additive serotonergic effects, which could theoretically lead to serotonin syndrome. Always consult a healthcare professional before combining.
How quickly does it work?
Acute effects on brain activity and anxiety markers have been observed within hours of a single dose, suggesting a relatively rapid onset of action.
Will it improve memory?
EEG studies suggest enhanced memory-related brain waves, indicating potential for cognitive improvement. However, clinical memory outcomes need further dedicated study to confirm this benefit.
Is it addictive?
No evidence of addiction or dependence has been reported in clinical studies conducted to date, suggesting it is not addictive at recommended doses.
Research Sources
- https://pmc.ncbi.nlm.nih.gov/articles/PMC3828542/ – This double-blind, placebo-controlled fMRI study with 16 healthy adults found that a single 25 mg dose of Zembrin® reduced amygdala reactivity to fearful faces and decreased amygdala–hypothalamus coupling, indicating anxiolytic potential. The study suggests a direct impact on brain regions involved in processing fear and anxiety.
- https://pmc.ncbi.nlm.nih.gov/articles/PMC8762184/ – This randomized, double-blind, placebo-controlled trial involving 60 healthy adults (40–75 years) showed that 25 mg or 50 mg doses of Zembrin® increased frontal EEG delta and alpha power during cognitive and emotional challenges. This suggests improved attention, memory, and calmness, indicating cognitive-enhancing effects.
- https://core.ac.uk/download/pdf/188223681.pdf – This in vitro cellular study investigated the effects of high-mesembrine extract, finding cytoprotective and anti-inflammatory effects in human monocytes and astrocytes, along with antioxidant properties. While preliminary and in vitro, it provides mechanistic insights into potential neuroprotective benefits.
- https://medcraveonline.com/IJCAM/exploring-standardized-zembrinreg-extracts-from-the-south-african-plant-sceletium-tortuosum-in-dual-targeting-phosphodiesterase-4-pde-4-and-serotonin-reuptake-inhibition-as-potential-treatment-in-schizophrenia.html – This review and pharmacological profiling study highlighted mesembrenone as a potent PDE4 inhibitor and discussed how the dual SSRI and PDE4 inhibition mechanisms of Sceletium tortuosum may underlie its therapeutic potential for mood and cognitive benefits. It supports the mechanistic rationale for the extract's effects.
